Mixed Trends in Pharma Stocks as Some Decline and Others Rise Amid Volume Spikes
Several pharmaceutical stocks showed mixed performance on the NSE, with Sun Pharmaceutical, Mankind Pharma, and Lupin Ltd declining for a fifth consecutive session amid a broadly lower NIFTY index. In contrast, Aurobindo Pharma rose for the third straight session, outperforming the NIFTY and Nifty Pharma indices. Pfizer Ltd and other pharma companies experienced significant volume surges, though Pfizer's stock price slipped. Overall, the sector displayed varied trends with some stocks falling despite a modest rise in the Nifty Pharma index over the past month.
First-hand measurement across 5 sources
We measured how 5 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (48/100). Lens Score 33/100.
Outlets measured: businessstandard, businessstandard, businessstandard, businessstandard, businessstandard. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (45–50/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
businessstandard broke this story on 8 Sept, 09:24 am. Other outlets followed.